EGLN1 and neoplasm: On the other hand, the genetic polymorphisms of EGLN1 have been commonly reported to be related to disease development, such as tumor aggressiveness (35), erythrocytosis (36–38), AMS (39, 40), and HA pulmonary edema (41).